Wavelength will be exhibiting at the GLOBAL VIRTUAL CONFERENCE ON MEDICAL CANNABIS AND CANNABIDIOL 2021 June 3rd and 4th
Wavelength Pharmaceuticals is a world class developer and manufacturer of high-quality APIs and a leading provider of API custom synthesis and manufacturing services. Experts in complex small molecule chemistry, process optimization and scale-up, serving more than 250 customers in 50 countries, having 32 years of exceptional regulatory track record with all leading global regulatory authorities. Wavelength produces 40 different APIs that range from grams to multi-tons scale, including injectables, highly potent, cytotoxic and controlled APIs.